Navigation Links
New HemCon/Seal-On Nasal Plugs Control Nosebleeds Quickly, Effectively and Comfortably
Date:7/14/2009

Wound Care Innovator Introduces Easy-to-Use Products for Professional and Consumer Use

Portland, Ore. (Vocus) July 14, 2009 -- HemCon Medical Technologies, Inc. today announced that its new HemCon Nasal Plugs and Seal-On devices are now available for use in both professional and home settings for anterior nasal bleeding. The nasal care products will be available from HemCon directly to consumers under the Seal-On brand, and for professionals under the HemCon Nasal Plug brand through distribution partners.

Designed for ease of use, the HemCon Nasal Plugs are comprised of a PVA foam impregnated with a proprietary, active ingredient, m.doc, a microdispersed oxidized cellulose. When in contact with blood, the dressing rapidly expands to provide pressure and absorb blood, offering patients a quick, comfortable and reliable solution to stop nasal bleeding. "My crews are thrilled with the HemCon Nasal Plugs. They work incredibly fast and really make a difference when treating nosebleeds in the field. We look forward to carrying them on all of our ambulances from now on," said Vic Cram, Paramedic Coordinator, Columbine Ambulance in Littleton, CO.

Unlike other devices, the HemCon dressings are both pain and burn free. The exterior of the plugs are coated and prevent the plugs from sticking to the walls of the nose during removal. When bleeding has been controlled, the patient can carefully remove the plug from the nose and discard it. Ready for removal within an hour, there is no need to keep these plugs in place long term, blocking patient airways or requiring a revisit to an M.D. for removal.

"Every year, nearly half a million people seek treatment for heavy nose bleeds that could be better treated with our dressings," said John W. Morgan, CEO of HemCon. "HemCon Nasal Plugs offer an easy solution to halt bleeding comfortably and rapidly, saving time for patients and caregivers alike."

Heavy nosebleeds can be triggered by a number of physical and environmental factors, including age, medical conditions, and climate. According to a recent Harris Interactive poll, one out of every five adults surveyed experienced a nosebleed in the past 12 months. It is estimated that one in every 200 emergency room visits are due to nosebleeds.

About HemCon Medical Technologies, Inc.
HemCon Medical Technologies, Inc. is a leading global developer of advanced medical products designed to improve the standard of patient care. The company is responsible for developing the chitosan-based HemCon dressing used by thousands of military and civilian first responders and is changing wound care best practices in hospital, dental and clinical settings. In addition, HemCon is leading the charge to develop and license unique, life-saving medical advances, including Lyophilized Human Plasma and NanospiderTM technologies. HemCon is headquartered in Portland, Ore., with additional commercial operations in Ireland; England; Germany and the Czech Republic. For more information, please visit www.hemcon.com.

Public Relations Contact:
Nicole Elovitz
HemCon Medical Technologies, Inc.
503-245-0459

# # #

Read the full story at http://www.prweb.com/releases/HemCon/Seal-On_Nasal_Plugs/prweb2639424.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Nasal Anthrax Vaccine Proves Effective in Animal Study
2. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
3. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
4. Nosefrida Nasal Aspirator - A Parents Alternative to Medicines on the Verge of FDA Ban
5. As Cold & Flu Season Nears, New Baby Nasal Aspirator Offers Safe and Effective Alternative to FDA-Discouraged Medicines
6. U.S. Advisers OK Nasal Spray Flu Vaccine for Young Children
7. New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis
8. Saline Irrigation Eases Chronic Nasal Symptoms
9. Protein Nasal Spray Revives Sleep-Deprived Monkeys
10. Saline Nasal Wash Helps Kids Fight Colds, Flu
11. Nasal polyps from analgesics
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New HemCon/Seal-On Nasal Plugs Control Nosebleeds Quickly, Effectively and Comfortably 
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
(Date:4/28/2017)... ... 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... to and which He does not. Yisrayl says with so many titles and names ... name, but he says with a little Scripture, backed with a lot of research, the ...
(Date:4/28/2017)... ... 28, 2017 , ... Intellitec Solutions announced the publication of ... Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software package. With ... care, Brooke Grove now has the capability to achieve its goal for a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor ... leant his presence to an educational purpose as the host of the “Informed” series. ... cancer. In a recent episode, the series focuses on thyroid cancer. , Although thyroid ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
Breaking Medicine Technology: